Top

Published in:

01-05-2018 | Original Contributions

Duodenal Exclusion but Not Sleeve Gastrectomy Preserves Insulin Secretion, Making It the More Effective Metabolic Procedure

Authors: Claudia Laessle, Gergana Nenova, Goran Marjanovic, Gabriel Seifert, Lampros Kousoulas, Bernd Jaenigen, Stefan Fichtner-Feigl, Jodok Matthias Fink

Published in: Obesity Surgery | Issue 5/2018

Abstract

Introduction

There is an ongoing debate on which procedure provides the best treatment for type 2 diabetes. Furthermore, the pathomechanisms of diabetes improvement of partly anatomically differing operations is not fully understood.

Methods

A loop duodenojejunostomy (DJOS) with exclusion of one third of intestinal length, a sleeve gastrectomy (SG), or a combination of DJOS + SG was performed in 8-week-old male ZDF rats. One, three, and six months after surgery, an oral glucose tolerance test and measurements of GLP-1, GIP, insulin, and bile acids were conducted.

Results

After an initial (4 weeks) equal glucose control, DJOS and DJOS + SG showed significantly lower glucose levels than SG 3 and 6 months after surgery. There was sharp decline of insulin levels in SG animals over time, whereas insulin levels in DJOS and DJOS + SG were preserved. GIP levels were significantly larger in both groups containing a sleeve at all three time points, whereas GLP-1 was equal in all groups at all time. Bile acid levels were significantly higher in the DJOS compared to the SG group at all time points. Interestingly, the additional SG in the DJOS + SG group led to lower bile acid levels 1 and 6 months postoperatively.

Conclusion

The effect of SG on glucose control was transient, whereas a duodenal exclusion was the more effective procedure in this model due to a sustained pancreatic function with a preserved insulin secretion.

WHO | Diabetes [Internet]. WHO. [cited 2016 Apr 19]. Available from: http://www.who.int/mediacentre/factsheets/fs312/en/.

Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442. https://doi.org/10.1371/journal.pmed.0030442.CrossRefPubMedPubMedCentral

Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222(3):339–52. https://doi.org/10.1097/00000658-199509000-00011.CrossRefPubMedPubMedCentral

Ribaric G, Buchwald JN, McGlennon TW. Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy: a systematic review and meta-analysis. Obes Surg. 2014;24(3):437–55. https://doi.org/10.1007/s11695-013-1160-3.CrossRefPubMed

Maggard-Gibbons M, Maglione M, Livhits M, et al. Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes: a systematic review. JAMA. 2013 Jun 5;309(21):2250–61. https://doi.org/10.1001/jama.2013.4851.CrossRefPubMed

Lee W-J, Hur KY, Lakadawala M, et al. Gastrointestinal metabolic surgery for the treatment of diabetic patients: a multi-institutional international study. J Gastrointest Surg. 2012;16(1):45–52. https://doi.org/10.1007/s11605-011-1740-2.CrossRefPubMed

Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577–85. https://doi.org/10.1056/NEJMoa1200111.CrossRefPubMed

Chai J, Zhang G, Liu S, et al. Exclusion of the distal ileum cannot reverse the anti-diabetic effects of duodenal-jejunal bypass surgery. Obes Surg. 2016;26(2):261–8. https://doi.org/10.1007/s11695-015-1745-0.CrossRefPubMed

Flynn CR, Albaugh VL, Cai S, et al. Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery. Nat Commun. 2015;6:7715. https://doi.org/10.1038/ncomms8715.CrossRefPubMedPubMedCentral

10.

Kohli R, Setchell KD, Kirby M, et al. A surgical model in male obese rats uncovers protective effects of bile acids post-bariatric surgery. Endocrinology. 2013;154(7):2341–51. https://doi.org/10.1210/en.2012-2069.CrossRefPubMedPubMedCentral

11.

Laessle C, Michelmichel S, Marjanovic G, Kuesters S, Seifert G, Hopt UT, et al. Common channel length in bypass surgery does not impact T2DM in diabetic Zucker rats. Obes Surg [Internet]. 2017 Mar 9 [cited 2017 Mar 27]; Available from: http://link.springer.com/10.1007/s11695-017-2611-z.

12.

Switzer NJ, Prasad S, Debru E, et al. Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review of long-term outcomes. Obes Surg. 2016;26(7):1616–21. https://doi.org/10.1007/s11695-016-2188-y.CrossRefPubMed

13.

Li J, Lai D, Wu D. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy to treat morbid obesity-related comorbidities: a systematic review and meta-analysis. Obes Surg. 2016;26(2):429–42. https://doi.org/10.1007/s11695-015-1996-9.CrossRefPubMed

14.

Aminian A, Brethauer SA, Andalib A, et al. Can sleeve gastrectomy “‘cure’” diabetes? Long-term metabolic effects of sleeve gastrectomy in patients with type 2 diabetes. Ann Surg. 2016 Oct 4;264(4):674–81. https://doi.org/10.1097/SLA.0000000000001857.CrossRefPubMed

15.

Peterli R, Steinert RE, Woelnerhanssen B, et al. Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg. 2012;22(5):740–8. https://doi.org/10.1007/s11695-012-0622-3.CrossRefPubMedPubMedCentral

16.

Romero F, Nicolau J, Flores L, et al. Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-en-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects. Surg Endosc. 2012;26(8):2231–9. https://doi.org/10.1007/s00464-012-2166-y.CrossRefPubMed

17.

Farey JE, Preda TC, Fisher OM, et al. Effect of laparoscopic sleeve gastrectomy on fasting gastrointestinal, pancreatic, and adipose-derived hormones and on non-esterified fatty acids. Obes Surg. 2017;27(2):399–407. https://doi.org/10.1007/s11695-016-2302-1.CrossRefPubMed

18.

Mallipedhi A, Prior SL, Barry JD, et al. Temporal changes in glucose homeostasis and incretin hormone response at 1 and 6 months after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2014;10(5):860–9. https://doi.org/10.1016/j.soard.2014.02.038.CrossRefPubMed

19.

Batterham RL, Cummings DE. Mechanisms of diabetes improvement following bariatric/metabolic surgery. Diabetes Care. 2016;39(6):893–901. https://doi.org/10.2337/dc16-0145.CrossRefPubMedPubMedCentral

20.

Marjanovic G, Holzner P, Kulemann B, et al. Pitfalls and technical aspects during the research of intestinal anastomotic healing in rats. Eur Surg Res. 2010;45(3–4):314–20. https://doi.org/10.1159/000320768.CrossRefPubMed

21.

Lee W-J, Chong K, Ser K-H, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus a randomized controlled trial. Arch Surg. 2011;146(2):143–8. https://doi.org/10.1001/archsurg.2010.326.CrossRefPubMed

22.

Eickhoff H, Louro TM, Matafome PN, et al. Amelioration of glycemic control by sleeve gastrectomy and gastric bypass in a lean animal model of type 2 diabetes: restoration of gut hormone profile. Obes Surg. 2015;25(1):7–18. https://doi.org/10.1007/s11695-014-1309-8.CrossRefPubMed

23.

Xu B, Yan X, Shao Y, et al. A comparative study of the effect of gastric bypass, sleeve gastrectomy, and duodenal–jejunal bypass on type-2 diabetes in non-obese rats. Obes Surg. 2015;25(10):1966–75. https://doi.org/10.1007/s11695-015-1835-z.CrossRefPubMed

24.

Wang K, Zhou X, Quach G, et al. Effect of sleeve gastrectomy plus side-to-side Jejunoileal anastomosis for type 2 diabetes control in an obese rat model. Obes Surg. 2016;26(4):797–804. https://doi.org/10.1007/s11695-015-1811-7.CrossRefPubMed

25.

Chambers AP, Smith EP, Begg DP, et al. Regulation of gastric emptying rate and its role in nutrient-induced GLP-1 secretion in rats after vertical sleeve gastrectomy. AJP Endocrinol Metab. 2014;306(4):E424–32.CrossRef

26.

Jiménez A, Casamitjana R, Flores L, et al. Long-term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects. Ann Surg. 2012;256(6):1023–9. https://doi.org/10.1097/SLA.0b013e318262ee6b.CrossRefPubMed

27.

Buchwald H, Menchaca HJ, Michalek VN, et al. Ileal effect on blood glucose, HbA1c, and GLP-1 in Goto-Kakizaki rats. Obes Surg. 2014;24(11):1954–60. https://doi.org/10.1007/s11695-014-1307-x.CrossRefPubMed

28.

Ye J, Hao Z, Mumphrey MB, et al. GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents. AJP Regul Integr Comp Physiol. 2014;306(5):R352–62.CrossRef

29.

Rao RS, Kini S. GIP and Bariatric surgery. Obes Surg. 2011;21(2):244–52. https://doi.org/10.1007/s11695-010-0305-x.CrossRefPubMed

30.

Kindel TL, Yoder SM, D’Alessio DA, et al. The effect of duodenal–jejunal bypass on glucose-dependent Insulinotropic polypeptide secretion in Wistar rats. Obes Surg. 2010;20(6):768–75. https://doi.org/10.1007/s11695-010-0095-1.CrossRefPubMedPubMedCentral

31.

Sun D, Liu S, Zhang G, et al. Type 2 diabetes control in a nonobese rat model using sleeve gastrectomy with duodenal–jejunal bypass (SGDJB). Obes Surg. 2012;22(12):1865–73. https://doi.org/10.1007/s11695-012-0744-7.CrossRefPubMed

32.

Ryan KK, Tremaroli V, Clemmensen C, et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature. 2014;509(7499):183–8. https://doi.org/10.1038/nature13135.CrossRefPubMedPubMedCentral

33.

Prawitt J, Caron S, Staels B. Glucose-lowering effects of intestinal bile acid sequestration through enhancement of splanchnic glucose utilization. Trends Endocrinol Metab. 2014;25(5):235–44. https://doi.org/10.1016/j.tem.2014.03.007.CrossRefPubMed

34.

Trabelsi M-S, Lestavel S, Staels B, Collet X. Intestinal bile acid receptors are key regulators of glucose homeostasis. Proc Nutr Soc. 2017;76(3):192–202.

35.

Speck M, Cho YM, Asadi A, et al. Duodenal-jejunal bypass protects GK rats from -cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1. AJP Endocrinol Metab. 2011;300(5):E923–32.CrossRef

36.

Zhou X, Qian B, Ji N, et al. Pancreatic hyperplasia after gastric bypass surgery in a GK rat model of non-obese type 2 diabetes. J Endocrinol. 2016;228(1):13–23.

37.

Zhong M-W, Liu S-Z, Zhang G-Y, et al. Effects of sleeve gastrectomy with jejuno-jejunal or jejuno-ileal loop on glycolipid metabolism in diabetic rats. World J Gastroenterol. 2016;22(32):7332–41. https://doi.org/10.3748/wjg.v22.i32.7332.CrossRefPubMedPubMedCentral

38.

Shimabukuro M, Zhou Y-T, Levi M, et al. Fatty acid-induced β cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci. 1998;95(5):2498–502. https://doi.org/10.1073/pnas.95.5.2498.CrossRefPubMedPubMedCentral

39.

Fed Glucose and Insulin Values for Obese Male ZDF Rats Fed Purina 5008 (January 2010 – July 2010) [Internet]. [cited 2016 Jun 3]. Available from: http://www.criver.com/files/pdfs/rms/zdf/rm_rm_r_glucose_insulin_zdf_july_2010.aspx.

Title: Duodenal Exclusion but Not Sleeve Gastrectomy Preserves Insulin Secretion, Making It the More Effective Metabolic Procedure
Authors: Claudia Laessle
Gergana Nenova
Goran Marjanovic
Gabriel Seifert
Lampros Kousoulas
Bernd Jaenigen
Stefan Fichtner-Feigl
Jodok Matthias Fink
Publication date: 01-05-2018
Publisher: Springer US
Published in: Obesity Surgery / Issue 5/2018
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-017-3045-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Duodenal Exclusion but Not Sleeve Gastrectomy Preserves Insulin Secretion, Making It the More Effective Metabolic Procedure

Abstract

Introduction

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 5/2018

Response Rates with the Spatz3 Adjustable Balloon

Ileal Transposition (IT) Surgery Changing the Ultrastructure of the Transposed Segment as well as Jejunum. Histomorphometric and Electron Microscopy Analysis

EUS-Guided Endoscopic Gastrointestinal Anastomosis with Lumen-Apposing Metal Stent: Feasibility, Safety, and Efficacy

Resolution of Symptomatic Obstructive Sleep Apnea Not Impacted by Preoperative Body Mass Index, Choice of Operation Between Sleeve Gastrectomy and Roux-en-Y Gastric Bypass Surgery, or Severity

The 15-cm Roux Limb: a Technical Misadventure

One Anastomosis Gastric Bypass and Risk of Cancer